Delivery Order SPE2DX22D0099-SPE2D826FAA9E
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $13,364.95 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which received no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. The contract's place...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,745.16 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 13, 2025, with an ultimate completion date of October 14, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $73,804.12 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $333,424.54 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 30, 2025, with an ultimate completion date of July 1, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $20,497.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 15, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA), operating through its Medical Supply Chain, awarded a delivery order valued at $1,961.76 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 16, 2025, with an ultimate completion date of October 17, 2025. This competitive award utilized firm fixed pricing with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $57,420.58 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 29, 2025, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $33,658.32 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $10,445.37 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 14, 2025, with a completion date of July 15, 2025. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical support vehicle running...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,181.21 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The contract was...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D826FAA9EDelivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $6,410.62 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 20, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price delivery order, which received no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of pharmaceutical products and medical supplies to federal military and veteran healthcare systems through its DLA prime contract, which is valued at $999,999,999.00 and extends through December 2026. The company's federal contract portfolio demonstrates extensive capability in delivering medications across multiple therapeutic domains, including specialty pharmaceuticals, generic drugs, vaccines, and medical devices, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 10/20/25 |